Jacobo Sellarés has been appointed Head of the Group, succeeding Antoni Torres, who has stepped down following his retirement. Torres remains affiliated with the Institute as an Emeritus Researcher. Also, the group changes its name and will henceforth be known as 'Mechanisms of Lung Injury: From Infection and Critical Illness to Fibrosis'.
Sellarés is a pulmonologist at Hospital Clínic Barcelona, where he heads the Interstitial Lung Disease Programme. He obtained his PhD from the University of Barcelona in 2010 and trained in systems biology at the University of Pittsburgh (2015-2017). He is also an Adjunct Professor at The Ohio State University in the United States. His research focuses on identifying biomarkers of disease progression and treatment response in sarcoidosis and pulmonary fibrosis. He co-chairs the SARCOIDOMICS European network of the European Respiratory Society (ERS) and has authored nearly one hundred scientific publications.
